Dr. Aguillon Prada is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
McGovern Medical School
6431 Fannin St
Houston, TX 77030
Summary
- Dr. Robier Aguillon Prada is an Intensivist and Nephrologist in Houston, TX and is affiliated with The University of Texas Houston McGovern Medical School. He received his medical degree from Industrial University of Santander Faculty of Medicine and has been in practice 14 years. He trained at UCSD, The University of Miami, Duke University and Cleveland Clinic
Education & Training
- Cleveland Clinic FoundationFellowship, Critical Care Medicine, 2013 - 2015
- Duke University HospitalFellowship, Nephrology, 2011 - 2013
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
- Industrial University of Santander Faculty of MedicineClass of 2003
Certifications & Licensure
- TX State Medical License 2021 - 2026
- OH State Medical License 2013 - 2023
- NC State Medical License 2011 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 3 citationsExercise-induced alterations in phospholipid hydrolysis, airway surfactant, and eicosanoids and their role in airway hyperresponsiveness in asthma.Ryan C. Murphy, Ying Lai, James D. Nolin, Robier Aguillon Prada, Arindam Chakrabarti
American Journal of Physiology. Lung Cellular and Molecular Physiology. 2021-02-03 - 47 citationsCanakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-1...Calvin C Sheng, Debasis Sahoo, Siddharth Dugar, Robier Aguillon Prada, Tom Kai Ming Wang
Clinical Cardiology. 2020-08-24 - 3 citationsIntratumoral Injection of Ad-ISF35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor RegressionMauricio Urquiza, Johanna Melo-Cardenas, R.A. Aguillon, Thomas J. Kipps, Januario E. Castro
Human Gene Therapy. 2015-01-01
Journal Articles
- Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, ...Paul C Cremer 1, Antonio Abbate 2, Kristin Hudock 3, Carla McWilliams 4, Jinesh Mehta 5, Steven Y Chang 6, Calvin C Sheng 1, Benjamin Van Tassell 2, Aldo Bonaventura 2..., Lancet Rheumatol . 2021 Jun;3(6):e410-e418, 3/17/2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: